Empliciti

Empliciti (elotuzumab) is a monoclonal antibody used in cancer treatment. Learn about its uses, effects, and precautions for intravenous administration.

Empliciti is primarily used in combination with other medications for the treatment of multiple myeloma, a type of blood cancer. It works by targeting specific proteins on cancer cells to help the immune system attack them. Patients often wonder, 'What is Empliciti used for?' and the answer lies in its role in managing certain types of cancer.

Common effects of Empliciti may include fatigue, fever, and infusion reactions. Some patients experience nausea or vomiting. These effects can vary and are not experienced by everyone who uses the medication.

Empliciti should be administered under medical supervision due to the risk of severe infusion reactions. Patients with a history of severe allergic reactions should inform their healthcare provider before use. Regular monitoring is essential during treatment.

Empliciti may interact with other medications, particularly those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also impact its effectiveness.